Guardant Health
GH
#3260
Rank
โ‚ฌ3.41 B
Marketcap
27,61ย โ‚ฌ
Share price
-3.64%
Change (1 day)
34.01%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ1.27 Billion

According to Guardant Health 's latest financial reports the company's total debt is โ‚ฌ1.27 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ1.22 B-4.07%
2022-12-31โ‚ฌ1.27 B5.24%
2021-12-31โ‚ฌ1.21 B74.61%
2020-12-31โ‚ฌ0.69 B1826.52%
2019-12-31โ‚ฌ36.06 M
2018-12-31N/A-100%
2017-12-31โ‚ฌ0.54 M-96.61%
2016-12-31โ‚ฌ16.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ0.41 B-67.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.84 B-33.42%๐Ÿ‡บ๐Ÿ‡ธ USA